Literature DB >> 772645

VP 16-213 in acute myelogenous leukaemia.

I E Smith, M E Gerken, H M Clink, T J McElwain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 772645      PMCID： PMC2496302          DOI： 10.1136/pgmj.52.604.66

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  3 in total

1.  Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion pattern.

Authors:  J H Goldie; L A Price; K R Harrap
Journal:  Eur J Cancer       Date:  1972-08       Impact factor: 9.162

2.  4'-Demethyl-epipodophyllotoxin thenylidene glucoside (VM 26), a podophyllum compound with a new mechanism of action.

Authors:  H Stähelin
Journal:  Eur J Cancer       Date:  1970-08       Impact factor: 9.162

3.  Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.

Authors:  W R Bruce; B E Meeker; F A Valeriote
Journal:  J Natl Cancer Inst       Date:  1966-08       Impact factor: 13.506
  3 in total
  6 in total

Review 1.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 2.  VP16-213 (etoposide). A critical review of its activity.

Authors:  F Cavalli
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 3.  Etoposide and teniposide in the treatment of acute leukemia.

Authors:  M Björkholm
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

Review 4.  The podophyllotoxin derivatives VP16-213 and VM26.

Authors:  B F Issell
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 5.  Podophyllotoxin derivative VP 16-213.

Authors:  A M Arnold
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

6.  [Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].

Authors:  H J Schmoll; N Niederle; W Achterrath
Journal:  Klin Wochenschr       Date:  1981-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.